Skip to main content
Top
Published in: Archives of Gynecology and Obstetrics 3/2012

01-03-2012 | Gynecologic Oncology

Cofactors in human papillomavirus infection and cervical carcinogenesis

Authors: Hakan Yetimalar, Burcu Kasap, Kulal Cukurova, Askin Yildiz, Adnan Keklik, Ferit Soylu

Published in: Archives of Gynecology and Obstetrics | Issue 3/2012

Login to get access

Abstract

Objective

This study aimed to identify the effect of various risk factors as the promoters of HPV infection, and to identify which HPV-positive women may have an increased risk of developing cervical cancer.

Methods

Smear preparations were examined and classified according to the Bethesda system. HPV-DNA detection and genotyping was carried out using polymerase chain reaction combined with reverse hybridization line-probe assays. Age, smoking habit, age at first sexual intercourse, number of sexual partners, number of term births, contraceptive method, progesterone therapy, history of sexually transmitted diseases, history or existence of warts and existence of cervical infection were recorded.

Results

642 women (96 women with abnormal cervical cytology and 546 women with normal cytology) provided cervical samples. Smoking habit, number of sexual partners, number of term births, history of sexually transmitted diseases, history or existence of warts and existence of cervical infection were identified as the promoters of HPV infection. History of sexually transmitted diseases, history or existence of warts and existence of cervical infection were identified as cofactors affecting progression from HPV infection to cervical cancer. Neither of contraceptive methods studied was related to HPV infection or coexistence with malign transformation to cervical cancer.

Conclusion

Information gathered from this study could be used to prioritize limited screening and treatment services to woman who have specific characteristics that may put them at an increased risk of HPV infection. Additionally, by identifying which women have a higher risk of cervical cancer; it may be possible to reduce the number of unnecessary colposcopies.
Literature
1.
go back to reference Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walboomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL (2001) High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101–106PubMed Kjaer SK, Chackerian B, van den Brule AJ, Svare EI, Paull G, Walboomers JM, Schiller JT, Bock JE, Sherman ME, Lowy DR, Meijer CL (2001) High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 10:101–106PubMed
2.
go back to reference Winer RL, Lee SK, Hughes JP, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157:218–226PubMedCrossRef Winer RL, Lee SK, Hughes JP, Kiviat NB, Koutsky LA (2003) Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol 157:218–226PubMedCrossRef
3.
go back to reference Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M (2002) A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94:1406–1414PubMedCrossRef Castle PE, Wacholder S, Lorincz AT, Scott DR, Sherman ME, Glass AG, Rush BB, Schussler JE, Schiffman M (2002) A prospective study of high-grade cervical neoplasia risk among human papillomavirus-infected women. J Natl Cancer Inst 94:1406–1414PubMedCrossRef
4.
go back to reference Lundberg GD (1989) The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis. JAMA 262:931–934CrossRef Lundberg GD (1989) The 1988 Bethesda system for reporting cervical/vaginal cytological diagnosis. JAMA 262:931–934CrossRef
5.
go back to reference Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902–907PubMedCrossRef Coutlee F, Gravitt P, Kornegay J, Hankins C, Richardson H, Lapointe N, Voyer H, Franco E (2002) Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. J Clin Microbiol 40:902–907PubMedCrossRef
6.
go back to reference van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779–787PubMedCrossRef van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40:779–787PubMedCrossRef
7.
go back to reference de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17–27PubMedCrossRef de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324:17–27PubMedCrossRef
8.
go back to reference Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRef Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19PubMedCrossRef
9.
go back to reference Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRef Munoz N, Bosch FX, de Sanjosé S, Herrero R, Castellsagué X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348:518–527PubMedCrossRef
10.
go back to reference Munoz N, Bosch FX, Castellsagué X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278–285PubMedCrossRef Munoz N, Bosch FX, Castellsagué X, Diaz M, de Sanjose S, Hammouda D, Shah KV, Meijer CJ (2004) Against which human papillomavirus types shall we vaccinate and screen? The international perspective. Int J Cancer 111:278–285PubMedCrossRef
11.
go back to reference Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedCrossRef
12.
go back to reference Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, Stolley PD, Fraumeni JF (1987) Epidemiology of cervical cancer by cell type. Cancer Res 47:1706–1711PubMed Brinton LA, Tashima KT, Lehman HF, Levine RS, Mallin K, Savitz DA, Stolley PD, Fraumeni JF (1987) Epidemiology of cervical cancer by cell type. Cancer Res 47:1706–1711PubMed
13.
go back to reference Ngelangel C, Munoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM (1998) Causes of cervical cancer in the Philippines: a case–control study. J Natl Cancer Inst 90:43–49PubMedCrossRef Ngelangel C, Munoz N, Bosch FX, Limson GM, Festin MR, Deacon J, Jacobs MV, Santamaria M, Meijer CJ, Walboomers JM (1998) Causes of cervical cancer in the Philippines: a case–control study. J Natl Cancer Inst 90:43–49PubMedCrossRef
14.
go back to reference Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM (1998) Risk factors for cervical cancer in Thailand: a case–control study. J Natl Cancer Inst 90:50–57PubMedCrossRef Chichareon S, Herrero R, Munoz N, Bosch FX, Jacobs MV, Deacon J, Santamaria M, Chongsuvivatwong V, Meijer CJ, Walboomers JM (1998) Risk factors for cervical cancer in Thailand: a case–control study. J Natl Cancer Inst 90:50–57PubMedCrossRef
15.
go back to reference Lacey JVJ, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12:153–161PubMedCrossRef Lacey JVJ, Frisch M, Brinton LA, Abbas FM, Barnes WA, Gravitt PE, Greenberg MD, Greene SM, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Zaino RJ, Hildesheim A (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Causes Control 12:153–161PubMedCrossRef
16.
go back to reference Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 83:1565–1572PubMedCrossRef Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, Peto J (2000) Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 83:1565–1572PubMedCrossRef
17.
go back to reference Altekruse SF, Lacey JVJ, Brinton LA, Gravitt PE, Silverberg SG, Barnes WAJ, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A (2003) Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 188:657–663PubMedCrossRef Altekruse SF, Lacey JVJ, Brinton LA, Gravitt PE, Silverberg SG, Barnes WAJ, Greenberg MD, Hadjimichael OC, McGowan L, Mortel R, Schwartz PE, Hildesheim A (2003) Comparison of human papillomavirus genotypes, sexual, and reproductive risk factors of cervical adenocarcinoma and squamous cell carcinoma: Northeastern United States. Am J Obstet Gynecol 188:657–663PubMedCrossRef
18.
go back to reference Munoz N, Franceschi S, Bosetti C, Moreno V, Smith JS, Shah KV, Meijer CJ, Bosch F (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 359:1093–1101PubMedCrossRef Munoz N, Franceschi S, Bosetti C, Moreno V, Smith JS, Shah KV, Meijer CJ, Bosch F (2002) Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet 359:1093–1101PubMedCrossRef
19.
go back to reference Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G (1988) Risk factors for adenocarcinoma of the cervix: a case–control study. Br J Cancer 57:201–204PubMedCrossRef Parazzini F, La Vecchia C, Negri E, Fasoli M, Cecchetti G (1988) Risk factors for adenocarcinoma of the cervix: a case–control study. Br J Cancer 57:201–204PubMedCrossRef
20.
go back to reference Brinton LA, Herrero R, Reeves WC, de Britton RC, Gaitan E, Tenorio F (1993) Risk factors for cervical cancer by histology. Gynecol Oncol 51:301–306PubMedCrossRef Brinton LA, Herrero R, Reeves WC, de Britton RC, Gaitan E, Tenorio F (1993) Risk factors for cervical cancer by histology. Gynecol Oncol 51:301–306PubMedCrossRef
21.
go back to reference Hildesheim A, Herrero R, Castle P, Wacholder S, Bratti M, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M (2001) HPV cofactors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226PubMedCrossRef Hildesheim A, Herrero R, Castle P, Wacholder S, Bratti M, Sherman ME, Lorincz AT, Burk RD, Morales J, Rodriguez AC, Helgesen K, Alfaro M, Hutchinson M, Balmaceda I, Greenberg M, Schiffman M (2001) HPV cofactors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer 84:1219–1226PubMedCrossRef
22.
go back to reference Kvale G, Heuch I, Nilssen S (1988) Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 58:820–824PubMedCrossRef Kvale G, Heuch I, Nilssen S (1988) Reproductive factors and risk of cervical cancer by cell type. A prospective study. Br J Cancer 58:820–824PubMedCrossRef
23.
go back to reference Bjorge T, Kravdal O (1996) Reproductive variables and risk of uterine cervical cancer in Norwegian registry data. Cancer Causes Control 7:351–357PubMedCrossRef Bjorge T, Kravdal O (1996) Reproductive variables and risk of uterine cervical cancer in Norwegian registry data. Cancer Causes Control 7:351–357PubMedCrossRef
24.
go back to reference Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case–control study. Lancet 359:1085–1092PubMedCrossRef Moreno V, Bosch FX, Munoz N, Meijer CJ, Shah KV, Walboomers JM, Herrero R, Franceschi S (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case–control study. Lancet 359:1085–1092PubMedCrossRef
25.
go back to reference Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159–1167PubMedCrossRef Smith JS, Green J, Berrington de Gonzalez A, Appleby P, Peto J, Plummer M, Franceschi S, Beral V (2003) Cervical cancer and use of hormonal contraceptives: a systematic review. Lancet 361:1159–1167PubMedCrossRef
26.
go back to reference La Vecchia C, Altieri A, Franceschi S, Tavani A (2001) Oral contraceptives and cancer: an update. Drug Saf 24:741–754PubMedCrossRef La Vecchia C, Altieri A, Franceschi S, Tavani A (2001) Oral contraceptives and cancer: an update. Drug Saf 24:741–754PubMedCrossRef
27.
go back to reference Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 29:725–735PubMedCrossRef Manhart LE, Koutsky LA (2002) Do condoms prevent genital HPV infection, external genital warts, or cervical neoplasia? A meta-analysis. Sex Transm Dis 29:725–735PubMedCrossRef
28.
go back to reference Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ (1996) Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65:601–606PubMedCrossRef Kjaer SK, van den Brule AJ, Bock JE, Poll PA, Engholm G, Sherman ME, Walboomers JM, Meijer CJ (1996) Human papillomavirus—the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer 65:601–606PubMedCrossRef
29.
go back to reference Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L (2001) Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 10:441–449PubMedCrossRef Coker AL, Sanders LC, Bond SM, Gerasimova T, Pirisi L (2001) Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion development. J Womens Health Gend Based Med 10:441–449PubMedCrossRef
30.
go back to reference Thomas DB, Ray RM (1995) Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO collaborative study of neoplasia and steroid contraceptives. Contraception 52:307–312PubMedCrossRef Thomas DB, Ray RM (1995) Depot-medroxyprogesterone acetate (DMPA) and risk of invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. WHO collaborative study of neoplasia and steroid contraceptives. Contraception 52:307–312PubMedCrossRef
31.
go back to reference Schmauz R, Okong P, de Villiers EM et al (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43:805–809PubMedCrossRef Schmauz R, Okong P, de Villiers EM et al (1989) Multiple infections in cases of cervical cancer from a high-incidence area in tropical Africa. Int J Cancer 43:805–809PubMedCrossRef
32.
go back to reference Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604–1613PubMedCrossRef Smith JS, Herrero R, Bosetti C, Munoz N, Bosch FX, Eluf-Neto J, Castellsague X, Meijer CJ, Van den Brule AJ, Franceschi S, Ashley R (2002) Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst 94:1604–1613PubMedCrossRef
33.
go back to reference Gravitt PE, Castle PE (2001) Chlamydia trachomatis and cervical squamous cell carcinoma. JAMA 285:1703–1704PubMedCrossRef Gravitt PE, Castle PE (2001) Chlamydia trachomatis and cervical squamous cell carcinoma. JAMA 285:1703–1704PubMedCrossRef
Metadata
Title
Cofactors in human papillomavirus infection and cervical carcinogenesis
Authors
Hakan Yetimalar
Burcu Kasap
Kulal Cukurova
Askin Yildiz
Adnan Keklik
Ferit Soylu
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
Archives of Gynecology and Obstetrics / Issue 3/2012
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-011-2034-3

Other articles of this Issue 3/2012

Archives of Gynecology and Obstetrics 3/2012 Go to the issue